Both in Pharmaceuticals
Teva Pharmaceutical Industries Limited vs Roivant Sciences
Over the past year TEVA returned +103.6% and ROIV returned +95.4%; their daily moves had a correlation of 0.17.
TEVA +103.6% ROIV +95.4%Growth of $1, one year, split-adjusted
| Metric | TEVA | ROIV |
|---|---|---|
| Price | $41.91 | $36.04 |
| Market cap | $48.88B | $26.03B |
| Today | +2.97% | +0.42% |
| 1 month | +5.7% | +0.7% |
| 6 months | +16.9% | +27.3% |
| Year to date | +34.3% | +66.1% |
| 1 year | +104.6% | +80.3% |
| Revenue growth (YoY) | −0.8% | −33.5% |
| Gross margin | 52.0% | 100.0% |
| Net margin | −13.9% | −13164.8% |
| P/E (TTM) | 69.1× | — |
| Price / sales | 2.8× | 3,456.3× |
| Net cash | -$12.94B | $3.84B |
| Dividend yield | — | — |
| Volatility (60d) | 28.5% | 49.0% |
| Short % of float | 2.4% | 8.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).